Gingras Marie-Claude, Kazan Jalal M, Pause Arnim
Department of Biochemistry, McGill University, Montréal, Québec, Canada H3G 1Y6.
Goodman Cancer Research Centre, McGill University, Montréal, Québec, Canada H3A 1A3.
Biochem Soc Trans. 2017 Jun 15;45(3):845-854. doi: 10.1042/BST20160332.
Sustained cellular signalling originated from the receptors located at the plasma membrane is widely associated with cancer susceptibility. Endosomal sorting and degradation of the cell surface receptors is therefore crucial to preventing chronic downstream signalling and tumorigenesis. Since the ndosomal orting omplexes equired for ransport (ESCRT) controls these processes, ESCRT components were proposed to act as tumour suppressor genes. However, the role of ESCRT components in tumorigenesis has not been clearly demonstrated. The ESCRT member HD-PTP/ was recently identified as a novel haplo-insufficient tumour suppressor and , in mice and humans. In this mini-review, we outline the role of the ESCRT components in cancer and summarize the functions of HD-PTP/ in tumorigenesis.
源自位于质膜上的受体的持续细胞信号传导与癌症易感性广泛相关。因此,细胞表面受体的内体分选和降解对于预防慢性下游信号传导和肿瘤发生至关重要。由于运输所需的内体分选复合物(ESCRT)控制这些过程,因此ESCRT组分被认为可作为肿瘤抑制基因发挥作用。然而,ESCRT组分在肿瘤发生中的作用尚未得到明确证实。ESCRT成员HD-PTP最近在小鼠和人类中被鉴定为一种新的单倍体不足肿瘤抑制因子。在本综述中,我们概述了ESCRT组分在癌症中的作用,并总结了HD-PTP在肿瘤发生中的功能。